Cancer Research SABCS  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 53, 1343-1347, March 15, 1993]
© 1993 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, C. D.
Right arrow Articles by Patterson, G. M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, C. D.
Right arrow Articles by Patterson, G. M. L.

Scytophycins, Novel Microfilament-depolymerizing Agents Which Circumvent P-Glycoprotein-mediated Multidrug Resistance1

Charles D. Smith2, Shmuel Carmeli, Richard E. Moore and Gregory M. L. Patterson

Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii 96813 [C. D. S.]; Department of Chemistry, University of Hawaii, Honolulu, Hawaii 96822 [R. E. M., G. M. L. P.]; and School of Chemistry, Tel Aviv University Ramat Aviv 69978, Israel [S. C.]

Cells demonstrating the multidrug resistance phenotype because of overexpression of P-glycoprotein, a drug efflux pump, are resistant to the cytotoxic effects of most natural product drugs. To determine if P-glycoprotein confers resistance to the syctophycins, a family of natural cytotoxic macrolides recently isolated from cyanobacteria of the family Scytonemataceae, we have characterized the effects of these compounds on drugsensitive (SKOV3) and drug-resistant (SKVLB1) human ovarian carcinoma cells. While SKVLB1 cells demonstrated > 150- and 10,000-fold decreases in sensitivity to Adriamycin and vinblastine, respectively, they were equally sensitive as SKOV3 cells to the antiproliferative effects of tolytoxin and certain related scytophycins. The SKVLB1 cells were 4- to 11-fold resistant to other scytophycins and were 14-fold resistant to cytochalasin B. Microfilaments in SKOV3 and SKVLB1 cells were depolymerized by similar concentrations of tolytoxin, while cytochalasin B was less potent toward SKVLB1 cells than SKOV3 cells. Both tolytoxin and cytochalasin B enhanced the cytotoxicity of vinblastine toward SKVLB1 cells; however, neither compound affected the sensitivity to Adriamycin or cisplatin. Verapamil markedly increased the accumulation of [3H]vinblastine by SKVLB1 cells, while cytochalasin B caused only modest increases, and tolytoxin had no effect on [3H]vinblastine accumulation. These results suggest that some of the scytophycins, including tolytoxin, are not subject to P-glycoprotein-mediated efflux from cells exhibiting multidrug resistance due to overexpression of this transport protein. These compounds may therefore be useful for killing drug-resistant tumor cells.

1 This research was supported by funds from the Cancer Research Center of Hawaii and NIH Grant CA12623.

2 To whom requests for reprints should be addressed, at Cancer Research Center of Hawaii, 1236 Lauhala Street, Honolulu, HI 96813.

Received 8/12/92. Accepted 1/ 5/93.




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
L. Belmont, G. Patterson, and D. Drubin
New actin mutants allow further characterization of the nucleotide binding cleft and drug binding sites
J. Cell Sci., January 5, 1999; 112(9): 1325 - 1336.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.